Shaffer Pharmacy
Outcome
A federal court entered a consent decree on January 15, 2021, ordering Shaffer Pharmacy and pharmacists Thomas Tadsen and Wilson Bunton to pay $375,000 in civil penalties and comply with an injunction barring dispensing of opioid-benzodiazepine combinations and other high-risk controlled substance prescriptions, resolving allegations of systematic CSA violations including dispensing fentanyl, oxycodone, hydrocodone, oxymorphone, and buprenorphine alongside dangerous concurrent drugs.
Details
Shaffer Pharmacy (Toledo, Ohio) — $375,000 Opioid-Benzo Combinations / Consent Decree (2021)
Outcome: A federal court entered a consent judgment and permanent injunction on January 15, 2021, ordering Shaffer Pharmacy, pharmacist-owner Thomas Tadsen, and pharmacist Wilson Bunton to pay $375,000 in civil penalties and comply with injunctive restrictions on opioid dispensing practices — resolving a 2021 complaint alleging the pharmacy dispensed highly abused opioids in dangerous combinations including fentanyl, oxycodone, hydrocodone, oxymorphone, and buprenorphine concurrent with benzodiazepines and muscle relaxants.
Shaffer Pharmacy is an independent pharmacy in Toledo, Ohio, operated by pharmacist-owner Thomas Tadsen with pharmacist Wilson Bunton. The DOJ filed a civil complaint on January 6, 2021, in the Northern District of Ohio, alleging that the pharmacy and both pharmacists violated the Controlled Substances Act by dispensing controlled substances while deliberately disregarding red flags of drug diversion and abuse.
The prescriptions at issue involved highly abused opioid painkillers including oxycodone, hydrocodone, oxymorphone, buprenorphine, and fentanyl — often dispensed in dangerous concurrent combinations with benzodiazepines (such as alprazolam/Xanax, indicated for anxiety) and muscle relaxants (such as carisoprodol/Soma). The concurrent opioid-benzodiazepine-muscle relaxant combination, known in diversion enforcement as the "holy trinity," is a pattern recognized by the DEA as a reliable indicator of drug abuse and diversion with no legitimate therapeutic purpose. The complaint alleged both pharmacists routinely filled such prescriptions without any red-flag assessment or documentation.
The consent judgment required $375,000 in civil penalties, prohibited the pharmacy and both pharmacists from dispensing concurrent opioid-benzodiazepine prescriptions, required documented red-flag review and justification before filling other high-risk orders, and mandated periodic compliance reviews.
Primary Source: Court Orders Toledo Pharmacy and Two Pharmacists to Stop Dispensing Dangerous Doses | DOJ
How Crucible Prevents This
Shaffer Pharmacy dispensed fentanyl, oxycodone, hydrocodone, oxymorphone, and buprenorphine alongside benzodiazepines and carisoprodol — multiple simultaneous controlled substance combinations that are recognized diversion and overdose risk indicators. Two licensed pharmacists at the same pharmacy engaged in this pattern simultaneously, confirming this was a practice-level culture failure rather than individual misconduct. Crucible's DECISIONS log would require documented red-flag assessment before any prescription bearing combination or dosage indicators — converting the implicit pharmacist discretion that both pharmacists exercised carelessly into a mandatory documented decision with named accountability.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works